A detailed history of Allworth Financial LP transactions in Axonics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 33 shares of AXNX stock, worth $2,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 38 13.16%
Holding current value
$2,342
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$67.3 - $69.67 $336 - $348
-5 Reduced 13.16%
33 $2,000
Q2 2024

Jul 23, 2024

BUY
$66.47 - $69.65 $997 - $1,044
15 Added 65.22%
38 $2,000
Q4 2023

Jan 24, 2024

BUY
$49.38 - $63.75 $1,135 - $1,466
23 New
23 $1,000
Q1 2023

Apr 18, 2023

SELL
$52.6 - $67.34 $263 - $336
-5 Reduced 16.13%
26 $1,000
Q3 2022

Oct 18, 2022

BUY
$57.96 - $78.12 $1,275 - $1,718
22 Added 244.44%
31 $2,000
Q2 2022

Jul 13, 2022

BUY
$39.5 - $64.42 $158 - $257
4 Added 80.0%
9 $1,000
Q1 2022

Apr 22, 2022

BUY
$43.74 - $62.76 $218 - $313
5 New
5 $0

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.